Gainesville, FL, United States of America

Arthur F Fluge

This inventor holds 1 USPTO granted patent. Top assignee: Kymera Therapeutics, Inc.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arthur F Fluge. Retrieved from https://idiyas.com/inventor/arthur-f-fluge

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Arthur F. Fluge: Innovator in IRAK Degraders

Introduction

Arthur F. Fluge is a notable inventor based in Gainesville, Florida. He has made significant contributions to the field of biochemistry, particularly through his innovative work on IRAK degraders. His research focuses on developing compounds and compositions that have practical applications in various therapeutic areas.

Latest Patents

Arthur holds one patent titled "IRAK degraders and uses thereof." This patent provides valuable insights into the compounds and methods for utilizing these degraders effectively. The invention aims to enhance the understanding and treatment of diseases related to IRAK pathways.

Career Highlights

Arthur is currently employed at Kymera Therapeutics, Inc., where he continues to advance his research and development efforts. His work at this company allows him to collaborate with other experts in the field and contribute to innovative solutions in drug development.

Collaborations

Arthur has worked alongside talented colleagues, including Nello Mainolfi and Nan Ji. These collaborations have fostered a dynamic research environment, enabling the team to explore new avenues in their scientific endeavors.

Conclusion

Arthur F. Fluge's contributions to the field of biochemistry, particularly through his patent on IRAK degraders, highlight his innovative spirit and dedication to advancing medical science. His work at Kymera Therapeutics, Inc. and collaborations with esteemed colleagues further emphasize his impact in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…